表紙
市場調査レポート

欧州の造影剤および放射性医薬品市場分析:2015年

Contrast Agents and Radiopharmaceuticals | Europe | 2015 | Market Analysis

発行 Millennium Research Group 商品コード 339435
出版日 ページ情報 英文 111 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
欧州の造影剤および放射性医薬品市場分析:2015年 Contrast Agents and Radiopharmaceuticals | Europe | 2015 | Market Analysis
出版日: 2015年09月10日 ページ情報: 英文 111 Pages
概要

償還規制が厳しくGBCAを取り巻く安全性に関する議論が続く中、欧州の造影剤および放射性医薬品市場は2023年にかけわずかに成長すると予測されています。これは放射性医薬品の平均薬価が上がり、欧州の高齢化において診断用画像処置の需要が増加しているためです。

当レポートでは、欧州の造影剤および放射性医薬品市場の現状と今後10年の予測とともに、セグメント別市場の競合動向、市場シェアなどをまとめています。

第1章 造影剤および放射性医薬品市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
  • 全般的市場動向
  • 競合ハイライト
  • 競合環境
  • 市場シェア
  • 市場因子と発展

第2章 放射性医薬品

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
    • SPECT
    • PET
  • 全般的市場動向
  • 競合ハイライト
  • 競合環境
  • 市場シェア

第3章 CTおよびX線造影剤市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
    • CT
    • 心血管用X線
    • 一般的X線
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア

第4章 MRI造影剤市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア

第5章 超音波造影剤市場

  • 市場ハイライト
  • 市場の定義
  • 市場予測データ
  • 全般的市場動向
  • 競合ハイライト
  • 市場シェア

第6章 調査方法

第7章 略語・イニシャル

第8章 参考文献

図表

目次
Product Code: RPEU50RP15

Introduction:

Despite stringent reimbursement regulations and the ongoing safety controversy surrounding GBCAs, the European contrast agent and radiopharmaceutical market will exhibit slight growth through 2023, propelled by ASP hikes in the radiopharmaceutical space and the increasing demand for diagnostic imaging procedures for Europe's aging population.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in Europe across a 10-year period.

Questions Answered in This Report:

  • Recent studies have questioned the safety of GBCAs.
    • How have European regulatory bodies and physicians responded to these studies?
    • To what extent will these studies impact the MRI contrast agent market through 2023?
    • How can competitors best respond to these safety concerns such that the impact on their products and revenues can be minimized?
  • Global fluctuations in the supply of Mo-99-the key isotope in the production of Tc for use in most SPECT procedures-will continue to negatively impact the market going forward.
    • To what extent will supply limitations affect revenue growth in the European SPECT radiopharmaceutical market?
    • What strategies will vendors and facilities employ in response to supply fluctuations?
  • Less contrast material is being used per patient procedure in Europe.
    • What are some of the key factors driving this trend?
    • Which markets will be the most impacted by this shift in usage?
  • The European market is highly competitive compared to the US market.
    • What are the key factors end users look for in a product?
    • How do local competitors fare compared to MNCs in the European contrast agent and radiopharmaceutical market?
    • How can smaller companies best position themselves to garner more market share going forward?

Table of Contents

  • Table of Contents
  • Tables and Figures
  • Executive Summary
  • Version History

1. Contrast Agent and Radiopharmaceutical Market

  • 1.1. Market Highlights
  • 1.2. Market Definitions
  • 1.3. Market Forecast Data
  • 1.4. General Market Trends
  • 1.5. Competitive Highlights
  • 1.6. Competitive Landscape
  • 1.7. Market Shares
  • 1.8. Market Factors and Developments

2. Radiopharmaceutical Market

  • 2.1. Market Highlights
  • 2.2. Market Definitions
  • 2.3. Market Forecast Data
    • 2.3.1. SPECT Radiopharmaceuticals
    • 2.3.2. PET Radiopharmaceuticals
  • 2.4. General Market Trends
  • 2.5. Competitive Highlights
  • 2.6. Competitive Landscape
  • 2.7. Market Shares

3. CT and X-Ray Contrast Agent Market

  • 3.1. Market Highlights
  • 3.2. Market Definitions
  • 3.3. Market Forecast Data
    • 3.3.1. CT
    • 3.3.2. Cardiovascular X-Ray
    • 3.3.3. Conventional X-Ray
  • 3.4. General Market Trends
  • 3.5. Competitive Highlights
  • 3.6. Market Shares

4. MRI Contrast Agent Market

  • 4.1. Market Highlights
  • 4.2. Market Definitions
  • 4.3. Market Forecast Data
  • 4.4. General Market Trends
  • 4.5. Competitive Highlights
  • 4.6. Market Shares

5. Ultrasound Contrast Agent Market

  • 5.1. Market Highlights
  • 5.2. Market Definitions
  • 5.3. Market Forecast Data
  • 5.4. General Market Trends
  • 5.5. Competitive Highlights
  • 5.6. Market Share Rankings

Appendix: Methodology

Appendix: Acronyms and Initialisms

Appendix: Bibliography

Tables and Figures

  • Figure 1: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2013--2023
  • Table 1: Contrast Agent and Radiopharmaceutical Market Landscape, Europe (USD), 2014 and 2023
  • Table 2: Contrast Agent and Radiopharmaceutical Procedure Market Share Rankings, by Product Type, Europe, 2014
  • Table 3: Companies Mentioned
  • Table 4: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe
  • Table 5: Recent Events in the Contrast Agent and Radiopharmaceutical Market, Europe
  • Table 6: Geographies Covered, Europe
  • Table 7: Average Currency Exchange Rates
  • Table 8: Contrast Agents and Radiopharmaceuticals Covered, Europe
  • Table 9: Version History
  • Figure 2: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2013--2023
  • Figure 3: Contrast Agent and Radiopharmaceutical Market, by Country, Europe (USD), 2013--2023
  • Table 10: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2013--2023
  • Table 11: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (EUR and GBP), 2013--2023
  • Table 12: Contrast Agent and Radiopharmaceutical Market Growth, by Product Type, Europe, 2014--2023
  • Table 13: Contrast Agent and Radiopharmaceutical Market, by Country, Europe (USD), 2013--2023
  • Table 14: Contrast Agent and Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 15: Contrast Agent and Radiopharmaceutical Market Growth, by Country, Europe, 2014--2023
  • Figure 4: Contrast Agent and Radiopharmaceutical Procedure Market Shares, Europe, 2014
  • Table 16: Contrast Agent and Radiopharmaceutical Procedure Market Shares, by Country, Europe, 2014
  • Table 17: Contrast Agent and Radiopharmaceutical Procedure Market Shares, by Product Type, Europe, 2014
  • Table 18: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe
  • Table 19: Recent Events in the Contrast Agent and Radiopharmaceutical Market, Europe
  • Figure 5: Radiopharmaceutical Market, by Product Type, Europe (USD), 2013--2023
  • Figure 6: Radiopharmaceutical Market, by Country, Europe (USD), 2013--2023
  • Table 20: Radiopharmaceutical Market, by Product Type, Europe (USD), 2013--2023
  • Table 21: Radiopharmaceutical Market, by Product Type, Europe (EUR and GBP), 2013--2023
  • Table 22: Radiopharmaceutical Market Growth, by Product Type, Europe, 2014-- 2023
  • Table 23: Radiopharmaceutical Market, by Country, Europe (USD), 2013--2023
  • Table 24: Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2013-- 2023
  • Table 25: Radiopharmaceutical Market Growth, by Country, Europe, 2014--2023
  • Table 26: Nuclear Medicine System Installed Base, by Product Type, Europe, 2013-- 2023
  • Table 27: Nuclear Medicine System Installed Base, by Country, Europe, 2013--2023
  • Table 28: SPECT Radiopharmaceutical Market, by Country, Europe (USD), 2013-- 2023
  • Table 29: SPECT Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 30: SPECT Radiopharmaceutical Market Growth, by Country, Europe, 2014-- 2023
  • Table 31: SPECT Radiopharmaceutical Installed Base, by Country, Europe, 2013-- 2023
  • Table 32: PET Radiopharmaceutical Market, by Country, Europe (USD), 2013--2023
  • Table 33: PET Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 34: PET Radiopharmaceutical Market Growth, by Country, Europe, 2014--2023
  • Table 35: PET Radiopharmaceutical Installed Base, by Country, Europe, 2013--2023
  • Figure 7: SPECT Radiopharmaceutical Procedure Market Shares, Europe, 2014
  • Table 36: SPECT Radiopharmaceutical Procedure Market Shares, by Country, Europe, 2014
  • Figure 8: CT and X--Ray Contrast Agent Market, by Product Type, Europe (USD), 2013--2023
  • Figure 9: CT and X--Ray Contrast Agent Market, by Country, Europe (USD), 2013-- 2023
  • Table 37: CT and X--Ray Contrast Agent Market, by Product Type, Europe (USD), 2013--2023
  • Table 38: CT and X--Ray Contrast Agent Market, by Product Type, Europe (EUR and GBP), 2013--2023
  • Table 39: CT and X--Ray Contrast Agent Market Growth, by Product Type, Europe, 2014--2023
  • Table 40: CT and X--Ray Contrast Agent Market, by Country, Europe (USD), 2013-- 2023
  • Table 41: CT and X--Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 42: CT and X--Ray Contrast Agent Market Growth, by Country, Europe, 2014-- 2023
  • Table 43: CT and X--Ray System Installed Base, by Country, Europe, 2013--2023
  • Table 44: CT System Installed Base, by Country, Europe, 2013--2023
  • Table 45: X--Ray System Installed Base, by Country, Europe, 2013--2023
  • Table 46: CT Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 47: CT Contrast Agent Market, by Country, Europe (EUR and GBP), 2013-- 2023
  • Table 48: CT Contrast Agent Market Growth, by Country, Europe, 2014--2023
  • Table 49: Cardiovascular X--Ray Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 50: Cardiovascular X--Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 51: Cardiovascular X--Ray Contrast Agent Market Growth, by Country, Europe, 2014--2023
  • Table 52: Conventional X--Ray Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 53: Conventional X--Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 54: Conventional X--Ray Contrast Agent Market Growth, by Country, Europe, 2014--2023
  • Figure 10: CT and X--Ray Contrast Agent Procedure Market Shares, Europe, 2014
  • Table 55: CT and X--Ray Contrast Agent Procedure Market Shares, by Country, Europe, 2014
  • Figure 11: MRI Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 56: MRI Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 57: MRI Contrast Agent Market, by Country, Europe (EUR and GBP), 2013-- 2023
  • Table 58: MRI Contrast Agent Market Growth, by Country, Europe, 2014--2023
  • Table 59: MRI System Installed Base, by Country, Europe, 2013--2023
  • Figure 12: MRI Contrast Agent Procedure Market Shares, Europe, 2014
  • Table 60: MRI Contrast Agent Procedure Market Shares, by Country, Europe, 2014
  • Figure 13: Ultrasound Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 61: Ultrasound Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 62: Ultrasound Contrast Agent Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 63: Ultrasound Contrast Agent Market Growth, by Country, Europe, 2014-- 2023
  • Table 64: Ultrasound Contrast Agent Revenue Market Share Rankings, Europe, 2014
  • Table 65: Acronyms and Initialisms
Back to Top